Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yutaka Niihara

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA

Biography

Dr. Niihara has been involved in patient care and research for sickle cell disease for most of his career, is the founder of Emmaus Life Sciences, Inc., and the principal inventor of Endari, an L-glutamine therapy for treatment of sickle cell disease approved by FDA in July 2017. Additionally, his laboratory focuses on regenerative medicine using cell sheet technology. This treatment uses autologous progenitor cell sheets to repair damaged organs such as cornea epithelium and myocardium.
Research Interest

Sickle cell disease - Cancer & Carcinogenesis - Blood & Blood Products & Transfusions - Biological markers and Oncology Specialized Techniques in Research: - Red cell enzyme studies - Red cell nucleotide analysis

 

Publications

Global Speakers in the subject

Global Experts in the subject

Top